Journal Home
Search for

Volume 20, Issue 2, Pages 112-120 (March 2010)


View previous. 12 of 33 View next.

Effects of Chromium Histidinate on Renal Function, Oxidative Stress, and Heat-Shock Proteins in Fat-Fed and Streptozotocin-Treated Rats

Ayhan Dogukan, MD, Mehmet Tuzcu, PhD, Vijaya Juturu, PhD, Gurkan Cikim, MD§, İbrahim Ozercan, MD, James Komorowski, MSc, Kazim Sahin, DVM, PhD#Corresponding Author Informationemail address

published online 21 July 2009.

Objective

Chromium is an essential element for carbohydrate, fat, and protein metabolism. The therapeutic potential of chromium histidinate (CrHis) in the treatment of diabetes has been elucidated. The present study investigated the effects of CrHis on serum parameters of renal function, on oxidative stress markers (malondialdehyde [MDA] and 8-isoprostane), and on the expression of heat-shock proteins (HSPs) in rats.

Methods

Male Wistar rats (n=60, 8 weeks old) were divided into four groups. Group 1 received a standard diet (12% of calories as fat). Group 2 received a standard diet, plus CrHis. Group 3 received a high-fat diet (40% of calories as fat) for 2 weeks, and was then injected with streptozotocin (STZ) on day 14 (STZ, 40mg/kg intraperitoneally). Group 4 was treated in the same way as group 3 (HFD/STZ), but was supplemented with 110 μg CrHis/kg/body weight/day. Oxidative stress in the kidneys of diabetic rats was evidenced by an elevation in levels of MDA and 8-isoprostane. Protein concentrations of HSP60 and HSP70 in renal tissue were determined by Western blot analyses.

Results

Chromium histidinate supplementation lowered kidney concentrations of MDA, 8-isoprostane levels, serum urea-N, and creatinine, and reduced the severity of renal damage in the STZ-treated group (i.e., the diabetes-induced group). The expression of HSP60 and HSP70 was lower in the STZ group that received CrHis than in the group that did not. No significant effect of CrHis supplementation was detected in regard to the overall measured parameters in the control group.

Conclusions

Chromium histidinate significantly decreased lipid peroxidation levels and HSP expression in the kidneys of experimentally induced diabetic rats. This study supported the efficacy of CrHis in reducing renal risk factors and impairment because of diabetes.

 Department of Nephrology, School of Medicine, Firat University, Elazig, Turkey

 Department of Biology, Faculty of Science, Firat University, Elazig, Turkey

 Technical Services and Scientific Affairs, Nutrition 21, Inc., Purchase, New York

§ Department of Biochemistry, Sarahatun Hospital, Elazig, Turkey

 Department of Pathology, School of Medicine, Firat University, Elazig, Turkey

# Department of Animal Nutrition, Faculty of Veterinary Science, Firat University, Elazig, Turkey

Corresponding Author InformationAddress reprint requests to Kazim Sahin, DVM, PhD, Department of Animal Nutrition, Faculty of Veterinary Science, Firat University, 23119 Elazig, Turkey.

PII: S1051-2276(09)00104-6

doi:10.1053/j.jrn.2009.04.009


View previous. 12 of 33 View next.